PremiumCompany AnnouncementsHUTCHMED (China) Limited Outlines Audit Committee Responsibilities HUTCHMED (China) Limited Strengthens Governance with New Nomination Committee Terms HUTCHMED Grants Share Options and LTIP Awards to Boost Talent Retention PremiumCompany AnnouncementsHUTCHMED to Present Promising Oncology Data at 2025 ASCO Meeting Hutchmed downgraded to Hold from Buy at HSBC HUTCHMED Successfully Passes All Resolutions at 2025 AGM PremiumThe FlyHutchmed says NDA for Tazverik granted conditional approval in China HUTCHMED Secures NMPA Approval for TAZVERIK® in China HUTCHMED’s Strong Financial Performance and Strategic Growth Drive Buy Rating